Precision Medicine and Clinical Omics” (PMCO) is an international, peer-reviewed journal aimed at bringing all aspects of genetic and 'omics (genomics, transcriptomics, proteomics, epigenomic, metagenomics, metabolomics, nutriomics) into the platform of precision medicine. PMCO publishes fundamental, preclinical, and clinical scientific researches related to precision medicine, particularly in the areas of high-throughput omic approaches. The journal renders an integrated forum for all academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, legal and ethical experts, and other healthcare professionals. Precision medicine represents a paradigm shift from the "one size fits all to tailored care for individuals or groups. The omics-based approaches are at the forefront of research to accelerate personalized medicine translation into clinical practice and health policies. Quick, evolving omic technologies have facilitated the generation of high-throughput data. This data need to be analyzed, integrated, and be shared among researchers. PMCO provides a platform for all involved players to share omic generated data in order to build up evidence-based content and further develop the future of precision medicine. JPMCO publishes original articles, review articles, short communications, letters to the editors, clinical trials, meta-analysis, and case reports.

Editorial Team